This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Covetrus, MWI propose remedies in US review of $3.5 billion deal

By Khushita Vasant ( October 6, 2026, 19:44 GMT | Insight) -- Covetrus and MWI Animal Health have submitted a remedy proposal to the US Federal Trade Commission and a dozen US states reviewing their $3.5 billion merger as the companies seek to address competition concerns and avoid a court challenge, MLex has learned. The proposed remedies are understood to have not satisfied the regulators, and an effort to block the deal cannot be ruled out.Covetrus and MWI Animal Health have submitted a remedy proposal to the US Federal Trade Commission and a dozen US states reviewing their $3.5 billion merger as the companies seek to address competition concerns and avoid a court challenge, MLex has learned. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login